Roche buys Zürich spin-off

Acquisition gives Roche access to antibody-boosting technology - and possible anti-cancer treatments in the pipeline
19 Sep 2005

Long live the corporate lab

Once upon a time, there were great businesses with massive central labs that did both product development and basic research. Today, most corporate labs have refocused on applied research. They do not know what they are missing.
19 Sep 2005

A licence to print money

Not everyone can produce a Google, Stanford's way of doing business is making other universities look with interest at the revenue possibilities of equity deals.
19 Sep 2005